By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Enanta Pharmaceuticals, Inc. 

500 Arsenal Street

Watertown  Massachusetts  02472  U.S.A.
Phone: 617-607-0800 Fax: 617-607-0530


SEARCH JOBS


Industry
Pharmaceutical






Company News
Enanta Pharmaceuticals, Inc. Reports Financial Results For Its Fiscal First Quarter Ended December 31, 2015 2/9/2016 9:42:44 AM
Enanta Pharmaceuticals, Inc. To Present At The LEERINK Partners 5th Annual Global Healthcare Conference 2/1/2016 10:33:21 AM
Enanta Pharmaceuticals, Inc. To Host Conference Call On February 8 At 4:30 P.M. ET To Discuss Financial Results For Its Fiscal First Quarter Ended December 31, 2015 1/28/2016 10:16:51 AM
Enanta Pharmaceuticals, Inc. Announces That AbbVie (ABBV) Has Initiated Enrollment Of Six Global Phase 3 Clinical Studies Of Its Once-Daily, Pan-Genotypic Hepatitis C Treatment 1/11/2016 12:57:12 PM
Enanta Pharmaceuticals, Inc. Announces New R&D Initiatives In Hepatitis B Virus And Respiratory Syncytial Virus And Plan To Provide Data Updates On Programs In NASH And HCV At The 34th Annual J.P. Morgan Healthcare Conference 1/11/2016 12:53:42 PM
Enanta Pharmaceuticals, Inc. Announces The U.S. FDA Grants Priority Review To AbbVie (ABBV)’s Supplemental New Drug Application For VIEKIRA PAK Without Ribavirin In Genotype 1B Chronic Hepatitis C Virus Patients With Compensated Cirrhosis 1/7/2016 10:36:48 AM
Enanta Pharmaceuticals, Inc. To Present At The 34th Annual J.P. Morgan Healthcare Conference Presentation To Be Webcast On January 13, 2016 At 11:00 A.M. PT 1/4/2016 7:47:58 AM
Enanta Pharmaceuticals, Inc. Announces The Election Of Bruce L.A. Carter, Ph.D. As Non-Executive Chairman Of The Board Of Directors 12/14/2015 9:29:49 AM
Enanta Pharmaceuticals, Inc. Announces FDA Acceptance Of AbbVie (ABBV)’s New Drug Application For A Once-Daily Formulation Of VIEKIRA PAK For The Treatment Of Genotype 1 Chronic Hepatitis C Virus Infection 12/2/2015 10:08:54 AM
Enanta Pharmaceuticals, Inc. Reports Financial Results For Its Fiscal Fourth Quarter And Year Ended September 30, 2015 11/24/2015 9:20:07 AM
12345678910...
//-->